Search the Newsreel

ARAY|Accuray Inc|Price:0.238|Chg%:+0.000

This article provides a detailed company profile for Accuray Inc (ARAY), a radiation therapy company. It outlines the company's business scope, including its CyberKnife and TomoTherapy platforms for cancer treatment, and details its financial data and market performance. Key information such as executive shareholdings, …

Price to sales forward of Accuray Incorporated – BX:XEJ

This article provides financial data for Accuray Incorporated (BX:XEJ), specifically its price-to-sales forward ratio. It highlights the company's financial overview within the health technology sector on BX Swiss.

Narayana Hrudayalaya Submits FY 2025-26 Annual Report; Consolidated Revenue Surges 44% to ₹78,960.35 Million

Enterprise value to revenue forward of Accuray Incorporated – NASDAQ:ARAY

The article discusses the enterprise value to revenue forward for Accuray Incorporated (NASDAQ: ARAY). It indicates that financial information specific to this metric would be displayed, likely within a table or chart, but the content provided is primarily navigational and structural rather than data-driven. …

Accuray Incorporated (XEJ) Q2 2025 Earnings Report - Results, Call & Slides

This article provides the Q2 2025 earnings report for Accuray Incorporated (XEJ), detailing an EPS beat of €0.04 with actual EPS at €0.02, compared to a consensus of -€0.02. The company also surpassed revenue expectations, reporting €101.75M against an expected €96.64M, marking an 8.33% …

Accuray Incorporated (ARAY) Q2 2026 Earnings: Steep EPS Miss Weighs on Shares - Earnings Power Value

Lewati 2 Tahun Penuh Tantangan, Megalestari Epack (EPAC) Siapkan 4 Strategi di 2024

Penjualan Megalestari Epack Sentosaraya (EPAC) turun 5,93% di semester I-2021

Asiaray Media Group Limited: Shareholders Board Members Managers and Company Profile | KYG0623M1015

Saray Matbaacilik Kagitcilik Kirtasiyecilik Ticaret Ve Sanayi A.S. İşlem Fikirleri — BIST:SAMAT